James N. Woody is Director at TETRALOGIC PHARMACEUTICALS CORP (TLOG). They have made 6 open-market trades across 3 companies since 2013, most recently 2023-12-15.
CIK 0001553355
6 open-market purchases totalling $3.5M since 2013, never a sale. Across 6 scored buys the stock is up 6.2% at ninety days, and 3.9 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 33% | 50% |
| Avg Move | -14.5% | -3.5% | +6.2% |
| Alpha | -12.9% | -4.5% | +3.9% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATNF | BUY | 2023-12-15 | 2023-12-18 | $0.19 | $5K | +30.4% | +16.2% | +8.6% |
| ATNF | BUY | 2023-05-18 | 2023-05-18 | $1.03 | $41K | +0.0% | +0.0% | -43.9% |
| ATNF | BUY | 2021-12-09 | 2021-12-10 | $4.27 | $107K | +3.0% | -17.7% | -25.6% |
| ATNF | BUY | 2020-11-09 | 2020-11-12 | $3.29 | $3K | -6.9% | -19.5% | +98.3% |
| TLOG | BUY | 2013-12-17 | 2013-12-19 | $7.00 | $1.8M | -81.5% | +0.5% | +0.5% |
| OMED | BUY | 2013-07-23 | 2013-07-23 | $17.00 | $1.5M | -32.1% | -0.5% | -0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.